Status and phase
Conditions
Treatments
About
Observe the efficacy and safety of G1(Sildenafil citrate tablets) in patients with COVID-19 under clinical actual diagnosis and treatment conditions
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients diagnosed as COVID-19:
Age≥18 years old,unlimited gender.
Patients who cannot stop the following drugs during the trial:erythromycin or strong inhibitors of CYP3A4 (such as saquinavir,ketoconazole,itraconazole),nonspecific inhibitors of CYP (such as cimetidine),HIV protease inhibitors (such as ritonavir).
Willing to participate in this study,signed Informed Consent and willing to participate in regular follow-up during the study.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
10 participants in 1 patient group
Loading...
Central trial contact
Qing Ning, Professor; Meifang Han, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal